Revenue
2021
2022
2023
MindMaze Therapeutics Holding SA (RLFTY)
Price—Loading quote
Net income
2021
2022
2023
Free cash flow
2022
2023
Total cash / debt
CashTotal debt
2020
2021
2022
2023
Financial statements
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Revenue | CHF6.3M | CHF7.1M | CHF4.5M |
| Research & development | CHF1.3M | CHF12.4M | CHF19.0M |
| Operating income | −CHF110.8M | −CHF52.0M | −CHF34.3M |
| EBITDAderived | −CHF107.5M | −CHF48.2M | −CHF32.3M |
| Net income | −CHF98.2M | −CHF50.8M | −CHF34.7M |
| Basic EPSper diluted share | -CHF 8.35 | -CHF 4.81 | -CHF 0.01 |
| Diluted EPSper diluted share | -CHF 8.35 | -CHF 4.81 | -CHF 0.01 |